543 research outputs found

    Relationships, Rigor, and Readiness: Strategies for Improving High Schools

    Get PDF
    This report offers lessons from the last in a series of three high school reform conferences sponsored by MDRC, the Council of the Great City Schools, and the National High School Alliance. This conference in June 2007 brought together leaders from 22 midsize school districts to describe their reform initiatives and to discuss ways in which research and evaluation can inform and complement school change

    Life After Prison: A Different Kind of Sentence?, a Forum at the Boston Center for the Arts

    Get PDF
    In September 2012, the Boston Center for the Arts (BCA) hosted a forum on life after prison as part of its series, Dialogue: Social Issues Examined Through the Playwright’s Pen. The forum coincided with performances at the Boston Center for the Arts of The MotherF**ker with the Hat, a play by Stephen Andy Guirgis about prisoner reentry. Andrea J. Cabral, then sheriff of Suffolk County and secretary of public safety in Massachusetts, moderated the forum in BCA’s Calderwood Pavilion, the same theater where SpeakEasy Stage Company was putting on the play. The four panelists work for nonprofit organizations primarily involved in assisting ex-offenders in making the transition back into society: Daniel Cordon, director of transitional employment at the Haley House in Roxbury and an ex-offender; Lyn Levy, founder and executive director of Span, Inc. in Boston; Gary Little, mentor coordinator at Span and an ex-offender; and Janet Rodriguez, founding president and CEO of SoHarlem in New York, which trains women given alternative sentences for nonviolent offenses to produce functional and wearable art. What follows is an edited and abridged transcript of their discussion of “Life After Prison: A Different Kind of Sentence?” and is based on the Boston Center for the Arts recording of this segment of Dialogue, which examines social issues through an artistic lens. A discussion period with the audience is summarized because the questions are not clearly audible and not all questioners stated their names and identities

    Quantifying gross vs. net agricultural land use change in Great Britain using the Integrated Administration and Control System

    Get PDF
    Land use change has impacts upon many natural processes, and is one of the key measures of anthropogenic disturbance on ecosystems. Agricultural land covers 70% of Great Britain's (GB) land surface and annually undergoes disturbance and change through farming practices such as crop rotation, ploughing and the planting and subsequent logging of forestry. It is important to quantify how much of GB's agricultural land undergoes such changes and what those changes are at an annual temporal resolution. Integrated Administration and Control System (IACS) data give annual snapshots of agricultural land use at the field level, allowing for high resolution spatiotemporal land use change studies at the national scale. Crucially, not only do the data allow for simple net change studies (total area change of a land use, in a specific areal unit) but also for gross change calculations (summation of all changes to and from a land use), meaning that both gains and losses to and from each land use category can be defined. In this study we analysed IACS data for GB from 2005 to 2013, and quantified gross change for over 90% of the agricultural area in GB for the first time. It was found that gross change totalled 63,500 km2 in GB compared to 20,600 km2 of net change, i.e. the real year-on-year change is, on average, three times larger than net change. This detailed information on nature of land use change allows for increased accuracy in modelling the impact of land use change on ecosystem processes and is directly applicable across EU member states, where collection of such survey data is a requirement. The modelled carbon flux associated with gross land use change was at times >100 Gg C y−1 larger than that based on net land use change for some land use transitions

    Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Coronary artery disease has been linked with genotypes for haptoglobin (Hp) which modulates extracorpuscular hemoglobin. We hypothesized that the Hp genotype would predict progression of coronary artery calcification (CAC), a marker of subclinical atherosclerosis.</p> <p>Methods</p> <p>CAC was measured three times in six years among 436 subjects with type 1 diabetes and 526 control subjects participating in the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study. Hp typing was performed on plasma samples by polyacrylamide gel electrophoresis.</p> <p>Results</p> <p>The Hp 2-2 genotype predicted development of significant CAC only in subjects with diabetes who were free of CAC at baseline (OR: 1.95, 95% CI: 1.07-3.56, p = 0.03), compared to those without the Hp 2-2 genotype, controlling for age, sex, blood pressure and HDL-cholesterol. Hp 2 appeared to have an allele-dose effect on development of CAC. Hp genotype did not predict CAC progression in individuals without diabetes.</p> <p>Conclusions</p> <p>Hp genotype may aid prediction of accelerated coronary atherosclerosis in subjects with type 1 diabetes.</p

    Real-world evidence supporting Tandem Control-IQ hybrid closed-loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations

    Get PDF
    BACKGROUND: The Tandem Control-IQ (CIQ) system has demonstrated significant glycemic improvements in large randomized controlled and real-world trials. Use of this system is lower in people with type 1 diabetes (T1D) government-sponsored insurance and those with type 2 diabetes (T2D). This analysis aimed to evaluate the performance of CIQ in these groups. METHODS AND MATERIALS: A retrospective analysis of CIQ users was performed. Users age ≥6 years with a t:slim X2 Pump and >30 days of continuous glucose monitoring (CGM) data pre-CIQ and >30 days post-CIQ technology initiation were included. RESULTS: A total of 4243 Medicare and 1332 Medicaid CIQ users were analyzed among whom 5075 had T1D and 500 had T2D. After starting CIQ, the Medicare beneficiaries group saw significant improvement in time in target range 70–180 mg/dL (TIR; 64% vs. 74%; P < 0.0001), glucose management index (GMI; 7.3% vs. 7.0%; P < 0.0001), and the percentage of users meeting American Diabetes Association (ADA) CGM Glucometrics Guidelines (12.8% vs. 26.3%; P < 0.0001). The Medicaid group also saw significant improvement in TIR (46% vs. 60%; P < 0.0001), GMI (7.9% vs. 7.5%; P < 0.0001), and percentage meeting ADA guidelines (5.7% vs. 13.4%; P < 0.0001). Patients with T2D and either insurance saw significant glycemic improvements. CONCLUSIONS: The CIQ system was effective in the Medicare and Medicaid groups in improving glycemic control. The T2D subgroup also demonstrated improved glycemic control with CIQ use. Glucometrics achieved in this analysis are comparable with those seen in previous randomized controlled clinical trials with the CIQ system

    A Pilot Study to Examine Maturation of Body Temperature Control in Preterm Infants

    Get PDF
    To test instrumentation and develop analytic models to use in a larger study to examine developmental trajectories of body temperature and peripheral perfusion from birth in extremely low birth weight (EBLW) infants

    Lost in translation: A disconnect between the science and Medicare coverage criteria for continuous subcutaneous insulin infusion

    Get PDF
    Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare & Medicaid Services (CMS) discount conclusive evidence that supports insulin pump use in diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the insulin pump eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes
    corecore